What happened
Dongbu updated a previously disclosed supply contract with Royal Canin Korea Ltd., now worth US$71.7M, about 5.86% of its recent annual revenue, running through Oct 2026.
For context, this single contract equals about 5.86% of the company's most recent annual revenue.
| Counterparty | Royal Canin Korea Ltd. |
|---|---|
| Contract value | US$71.7M |
| vs. recent revenue | 5.86% |
| Through | Oct 2026 (from Jan 2024) |
| Filed | 2026-08-24, [Amended] Supply contract signed |
| Source | DART rcept 20260824800603 → open original filing |
Source: DART. Information only, not investment advice.